{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:33:54Z","timestamp":1792427634194,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Heart and Stroke Foundation of Canada","award":["G-18-0022118"],"award-info":[{"award-number":["G-18-0022118"]}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","award":["RGPIN-2017-06119"],"award-info":[{"award-number":["RGPIN-2017-06119"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","award":["Canada Graduate Scholarships-Master\u2019s Program"],"award-info":[{"award-number":["Canada Graduate Scholarships-Master\u2019s Program"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fonds de recherche du Qu\u00e9bec - Sant\u00e9","award":["36749"],"award-info":[{"award-number":["36749"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12035-019-1539-9","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T15:02:47Z","timestamp":1552143767000},"page":"6521-6538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy"],"prefix":"10.1007","volume":"56","author":[{"given":"No\u00ebmie","family":"Jean LeBlanc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Menet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Parent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-\u00c8ve","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-6039","authenticated-orcid":false,"given":"Ayman","family":"ElAli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,9]]},"reference":[{"key":"1539_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1749-6632.2012.06691.x","volume":"1268","author":"U Dirnagl","year":"2012","unstructured":"Dirnagl U (2012) Pathobiology of injury after stroke: the neurovascular unit and beyond. Ann N Y Acad Sci 1268:21\u201325. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06691.x","journal-title":"Ann N Y Acad Sci"},{"key":"1539_CR2","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1161\/STROKEAHA.113.000856","volume":"44","author":"DF Hanley","year":"2013","unstructured":"Hanley DF, Awad IA, Vespa PM, Martin NA, Zuccarello M (2013) Hemorrhagic stroke: introduction. Stroke 44:S65\u2013S66. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.113.000856","journal-title":"Stroke"},{"key":"1539_CR3","doi-asserted-by":"publisher","first-page":"re4","DOI":"10.1126\/scisignal.2002886","volume":"5","author":"DM Hermann","year":"2012","unstructured":"Hermann DM, ElAli A (2012) The abluminal endothelial membrane in neurovascular remodeling in health and disease. Sci Signal 5:re4. \n                    https:\/\/doi.org\/10.1126\/scisignal.2002886","journal-title":"Sci Signal"},{"key":"1539_CR4","doi-asserted-by":"publisher","first-page":"ra72","DOI":"10.1126\/scisignal.2001213","volume":"3","author":"A ElAli","year":"2010","unstructured":"ElAli A, Hermann DM (2010) Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain. Sci Signal 3:ra72. \n                    https:\/\/doi.org\/10.1126\/scisignal.2001213","journal-title":"Sci Signal"},{"key":"1539_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","volume":"32","author":"KE Sandoval","year":"2008","unstructured":"Sandoval KE, Witt KA (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32:200\u2013219. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2008.08.005","journal-title":"Neurobiol Dis"},{"key":"1539_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000321965","volume":"65","author":"R Brouns","year":"2011","unstructured":"Brouns R, Wauters A, De Surgeloose D, Marien P, De Deyn PP (2011) Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol 65:23\u201331. \n                    https:\/\/doi.org\/10.1159\/000321965","journal-title":"Eur Neurol"},{"key":"1539_CR7","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1002\/cne.23582","volume":"522","author":"S Garbuzova-Davis","year":"2014","unstructured":"Garbuzova-Davis S, Haller E, Williams SN, Haim ED, Tajiri N, Hernandez-Ontiveros DG, Frisina-Deyo A, Boffeli SM et al (2014) Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage. J Comp Neurol 522:3120\u20133137. \n                    https:\/\/doi.org\/10.1002\/cne.23582","journal-title":"J Comp Neurol"},{"key":"1539_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm1735","volume":"14","author":"EH Lo","year":"2008","unstructured":"Lo EH (2008) A new penumbra: transitioning from injury into repair after stroke. Nat Med 14:497\u2013500. \n                    https:\/\/doi.org\/10.1038\/nm1735","journal-title":"Nat Med"},{"key":"1539_CR9","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1161\/01.STR.0000143219.16695.af","volume":"35","author":"X Wang","year":"2004","unstructured":"Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH (2004) Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 35:2726\u20132730. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000143219.16695.af","journal-title":"Stroke"},{"key":"1539_CR10","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1161\/STROKEAHA.109.192535","volume":"40","author":"GJ Zoppo Del","year":"2009","unstructured":"Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, American Heart Association Stroke C (2009) Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association\/American Stroke Association. Stroke 40:2945\u20132948. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.109.192535","journal-title":"Stroke"},{"key":"1539_CR11","doi-asserted-by":"publisher","unstructured":"Sussman ES, Connolly ES Jr (2013) Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol 4:69. doi: \n                    https:\/\/doi.org\/10.3389\/fneur.2013.00069","DOI":"10.3389\/fneur.2013.00069"},{"key":"1539_CR12","doi-asserted-by":"publisher","unstructured":"Zhang J, Yang Y, Sun H, Xing Y (2014) Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Transl Med 2(81). \n                    https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.08.08","DOI":"10.3978\/j.issn.2305-5839.2014.08.08"},{"key":"1539_CR13","doi-asserted-by":"publisher","unstructured":"Clevers H, Nusse,R (2012) Wnt\/beta-catenin signaling and disease. Cell 149:1192\u20131205. doi: \n                    https:\/\/doi.org\/10.1016\/j.cell.2012.05.012","DOI":"10.1016\/j.cell.2012.05.012"},{"key":"1539_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1083\/jcb.200806024","volume":"183","author":"S Liebner","year":"2008","unstructured":"Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A et al (2008) Wnt\/beta-catenin signaling controls development of the blood-brain. J Cell Biol 183:409\u2013417. \n                    https:\/\/doi.org\/10.1083\/jcb.200806024","journal-title":"J Cell Biol"},{"key":"1539_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/CIRCULATIONAHA.115.015982","volume":"133","author":"KA Tran","year":"2016","unstructured":"Tran KA, Zhang X, Predescu D, Huang X, Machado RF, Gothert JR, Malik AB, Valyi-Nagy T et al (2016) Endothelial beta-catenin signaling is required for maintaining adult blood-brain barrier integrity and central nervous system homeostasis. Circulation 133:177\u2013186. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015982","journal-title":"Circulation"},{"key":"1539_CR16","doi-asserted-by":"publisher","first-page":"E1168","DOI":"10.1073\/pnas.1609905114","volume":"114","author":"JE Lengfeld","year":"2017","unstructured":"Lengfeld JE, Lutz SE, Smith JR, Diaconu C, Scott C, Kofman SB, Choi C, Walsh CM et al (2017) Endothelial Wnt\/beta-catenin signaling reduces immune cell infiltration in multiple sclerosis. Proc Natl Acad Sci U S A 114:E1168\u2013E1177. \n                    https:\/\/doi.org\/10.1073\/pnas.1609905114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1539_CR17","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1161\/STROKEAHA.111.648923","volume":"43","author":"A ElAli","year":"2012","unstructured":"ElAli A, Urrutia A, Rubio-Araiz A, Hernandez-Jimenez M, Colado MI, Doeppner TR, Hermann DM (2012) Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication. Stroke 43:1647\u20131653. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.648923","journal-title":"Stroke"},{"key":"1539_CR18","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1242\/jcs.080580","volume":"124","author":"YZ Wang","year":"2011","unstructured":"Wang YZ, Yamagami T, Gan Q, Wang Y, Zhao T, Hamad S, Lott P, Schnittke N et al (2011) Canonical Wnt signaling promotes the proliferation and neurogenesis of peripheral olfactory stem cells during postnatal development and adult regeneration. J Cell Sci 124:1553\u20131563. \n                    https:\/\/doi.org\/10.1242\/jcs.080580","journal-title":"J Cell Sci"},{"key":"1539_CR19","doi-asserted-by":"publisher","unstructured":"Zhao Y, Wei ZZ, Zhang JY, Zhang Y, Won S, Sun J, Yu SP, Li J et al (2017) GSK-3\u03b2 inhibition induced neuroprotection, regeneration, and functional recovery after intracerebral hemorrhagic stroke. Cell Transplant 26:395\u2013407. \n                    https:\/\/doi.org\/10.3727\/096368916X694364","DOI":"10.3727\/096368916X694364"},{"key":"1539_CR20","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1007\/s12035-017-0478-6","volume":"55","author":"N Jean LeBlanc","year":"2018","unstructured":"Jean LeBlanc N, Guruswamy R, ElAli A (2018) Vascular endothelial growth factor isoform-B stimulates neurovascular repair after ischemic stroke by promoting the function of pericytes via vascular endothelial growth factor receptor-1. Mol Neurobiol 55:3611\u20133626. \n                    https:\/\/doi.org\/10.1007\/s12035-017-0478-6","journal-title":"Mol Neurobiol"},{"key":"1539_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature13324","volume":"509","author":"A Ben-Zvi","year":"2014","unstructured":"Ben-Zvi A, Lacoste B, Kur E, Andreone BJ, Mayshar Y, Yan H, Gu C (2014) Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature 509:507\u2013511. \n                    https:\/\/doi.org\/10.1038\/nature13324","journal-title":"Nature"},{"key":"1539_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1083\/jcb.34.1.207","volume":"34","author":"TS Reese","year":"1967","unstructured":"Reese TS, Karnovsky MJ (1967) Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34:207\u2013217","journal-title":"J Cell Biol"},{"key":"1539_CR23","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1161\/STROKEAHA.111.615559","volume":"42","author":"A ElAli","year":"2011","unstructured":"ElAli A, Doeppner TR, Zechariah A, Hermann DM (2011) Increased blood-brain barrier permeability and brain edema after focal cerebral ischemia induced by hyperlipidemia: role of lipid peroxidation and calpain-1\/2, matrix metalloproteinase-2\/9, and RhoA overactivation. Stroke 42:3238\u20133244. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.615559","journal-title":"Stroke"},{"key":"1539_CR24","doi-asserted-by":"publisher","first-page":"11864","DOI":"10.18632\/oncotarget.7689","volume":"7","author":"M Bordeleau","year":"2016","unstructured":"Bordeleau M, ElAli A, Rivest S (2016) Severe chronic cerebral hypoperfusion induces microglial dysfunction leading to memory loss in APPswe\/PS1 mice. Oncotarget 7:11864\u201311880. \n                    https:\/\/doi.org\/10.18632\/oncotarget.7689","journal-title":"Oncotarget"},{"key":"1539_CR25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/npp.2015.279","volume":"41","author":"A ElAli","year":"2016","unstructured":"ElAli A, Bordeleau M, Th\u00e9riault P, Filali M, Lampron A, Rivest S (2016) Tissue-plasminogen activator attenuates Alzheimer\u2019s disease-related pathology development in APPswe\/PS1 mice. Neuropsychopharmacology. 41:1297\u20131307. \n                    https:\/\/doi.org\/10.1038\/npp.2015.279","journal-title":"Neuropsychopharmacology."},{"key":"1539_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.brainres.2006.10.083","volume":"1130","author":"RC Brown","year":"2007","unstructured":"Brown RC, Morris AP, O\u2019Neil RG (2007) Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 1130:17\u201330. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2006.10.083","journal-title":"Brain Res"},{"key":"1539_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/ncb1752","volume":"10","author":"A Taddei","year":"2008","unstructured":"Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C et al (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923\u2013934. \n                    https:\/\/doi.org\/10.1038\/ncb1752","journal-title":"Nat Cell Biol"},{"key":"1539_CR28","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2012.05.002","volume":"149","author":"VS Li","year":"2012","unstructured":"Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, Mohammed S, Heck AJ et al (2012) Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 149:1245\u20131256. \n                    https:\/\/doi.org\/10.1016\/j.cell.2012.05.002","journal-title":"Cell"},{"key":"1539_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/01.STR.0000163050.39122.4f","volume":"36","author":"K Benchenane","year":"2005","unstructured":"Benchenane K, Berezowski V, Fern\u00e1ndez-Monreal M, Brillault J, Valable S, Dehouck MP, Cecchelli R, Vivien D et al (2005) Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process. Stroke 36:1065\u20131070","journal-title":"Stroke"},{"key":"1539_CR30","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.neuropharm.2009.12.017","volume":"58","author":"R Abu Fanne","year":"2010","unstructured":"Abu Fanne R, Nassar T, Yarovoi S, Rayan A, Lamensdorf I, Karakoveski M, Vadim P, Jammal M et al (2010) Blood-brain barrier permeability and tPA-mediated neurotoxicity. Neuropharmacology. 58:972\u2013980. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2009.12.017.","journal-title":"Neuropharmacology."},{"key":"1539_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/pr.57.2.4","volume":"57","author":"BT Hawkins","year":"2005","unstructured":"Hawkins BT, Davis TP (2005) The blood-brain barrier\/neurovascular unit in health and disease. Pharmacol Rev 57:173\u2013185. \n                    https:\/\/doi.org\/10.1124\/pr.57.2.4","journal-title":"Pharmacol Rev"},{"key":"1539_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0166-2236(00)01562-9","volume":"23","author":"SC Cramer","year":"2000","unstructured":"Cramer SC, Chopp M (2000) Recovery recapitulates ontogeny. Trends Neurosci 23:265\u2013271","journal-title":"Trends Neurosci"},{"key":"1539_CR33","doi-asserted-by":"publisher","first-page":"E2756","DOI":"10.3390\/ijms18122756","volume":"18","author":"T Knecht","year":"2017","unstructured":"Knecht T, Story J, Liu J, Davis W, Borlongan CV, Dela Pena IC (2017) Adjunctive therapy approaches for ischemic stroke: innovations to expand time window of treatment. Int J Mol Sci 18:E2756. \n                    https:\/\/doi.org\/10.3390\/ijms18122756","journal-title":"Int J Mol Sci"},{"key":"1539_CR34","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1161\/01.STR.28.5.957","volume":"28","author":"V Larrue","year":"1997","unstructured":"Larrue V, von Kumme R, Del Zoppo G, Bluhmki E (1997) Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28:957\u2013960","journal-title":"Stroke"},{"key":"1539_CR35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nm1387","volume":"12","author":"BQ Zhao","year":"2006","unstructured":"Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, Wang X, Lo EH (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441\u2013445. \n                    https:\/\/doi.org\/10.1038\/nm1387","journal-title":"Nat Med"},{"key":"1539_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.7150\/ijms.17514","volume":"14","author":"W Wang","year":"2017","unstructured":"Wang W, Li M, Wang Y, Wang Z, Zhang W, Guan F, Chen Q, Wang J (2017) GSK-3beta as a target for protection against transient cerebral ischemia. Int J Med Sci 14:333\u2013339. \n                    https:\/\/doi.org\/10.7150\/ijms","journal-title":"Int J Med Sci"},{"key":"1539_CR37","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.1158\/1078-0432.CCR-05-1099","volume":"11","author":"EB Carson-Walter","year":"2005","unstructured":"Carson-Walter EB, Hampton J, Shue E, Geynisman DM, Pillai PK, Sathanoori R, Madden SL, Hamilton R et al (2005) Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin Cancer Res 11:7643\u20137650. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1099","journal-title":"Clin Cancer Res"},{"key":"1539_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2202-9-29","volume":"9","author":"EH Shue","year":"2008","unstructured":"Shue EH, Carson-Walter EB, Liu Y, Winans BN, Ali ZS, Chen J, Walter KA (2008) Plasmalemmal vesicle associated protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models. BMC Neurosci 9:29. \n                    https:\/\/doi.org\/10.1186\/1471-2202-9-29","journal-title":"BMC Neurosci"},{"key":"1539_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nm0298-228","volume":"4","author":"YF Wang","year":"1998","unstructured":"Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4:228\u2013231","journal-title":"Nat Med"},{"key":"1539_CR40","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1007\/s12035-015-9607-2","volume":"53","author":"W Wang","year":"2016","unstructured":"Wang W, Li M, Wang Y, Li Q, Deng G, Wan J, Yang Q, Chen Q et al (2016) GSK-3beta inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt\/beta-catenin signaling pathway after acute ischemic stroke in rats. Mol Neurobiol 53:7028\u20137036. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9607-2","journal-title":"Mol Neurobiol"},{"key":"1539_CR41","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jval.2017.03.004","volume":"20","author":"DI Soeteman","year":"2017","unstructured":"Soeteman DI, Menzies NA, Pandya A (2017) Would a large tPA trial for those 4.5 to 6.0 hours from stroke onset be good value for information? Value Health 20:894\u2013901. \n                    https:\/\/doi.org\/10.1016\/j.jval.2017.03.004","journal-title":"Value Health"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1539-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-1539-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-1539-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T00:24:05Z","timestamp":1583627045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-1539-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1539"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-1539-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,9]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were performed according to the Canadian Council on Animal Care guidelines, as administered by the Universit\u00e9 Laval Animal Welfare Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}